Mariarosa Carta
Overview
Explore the profile of Mariarosa Carta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martino F, Fanton G, Zanetti F, Carta M, Nalesso F, Novara G
J Clin Med
. 2024 Feb;
13(4).
PMID: 38398457
Background: We conducted a retrospective epidemiological study about the prevalence of stage 5 chronic kidney disease (CKD) in a high-income district, comparing some demographic characteristics and outcomes of those patients...
2.
Virzi G, Mattiotti M, Milan Manani S, Gnappi M, Tantillo I, Corradi V, et al.
Blood Purif
. 2023 Nov;
53(4):316-324.
PMID: 37992697
Introduction: The present study aimed to monitor peritoneal neutrophil gelatinase-associated lipocalin (pNGAL) during peritonitis episodes and to enhance its diagnostic value by evaluating pNGAL at scheduled times in parallel with...
3.
Vidali M, Paleari R, Ceriotti F, Bernardini S, Giambini I, Brugnoni D, et al.
Clin Chim Acta
. 2023 Sep;
550:117564.
PMID: 37748747
Background And Aims: The monitoring of yearly distributions of HbA measured has been indicated as a reliable indicator of worldwide standardization. Materials And Methods: Measurements/year of HbA have been collected...
4.
Ranzato F, Roberti R, Deluca C, Carta M, Peretti A, Polo D, et al.
Neurol Sci
. 2023 Aug;
45(1):277-288.
PMID: 37548755
Background: There is little and controversial information about changes in plasma concentrations (PCs) or clinical events during coadministration of antiseizure medications (ASMs) and direct oral anticoagulants (DOACs). We aimed to...
5.
Virzi G, Mattiotti M, Milan Manani S, Gnappi M, Tantillo I, Corradi V, et al.
J Nephrol
. 2023 Jan;
36(7):2139-2141.
PMID: 36646971
No abstract available.
6.
Carta M, Pascarella M, Cappelletti A, Rassu M, Giavarina D
Diagnosis (Berl)
. 2022 Oct;
9(4):491-498.
PMID: 36181728
Objectives: Chemiluminescence immunoassay (CLIA) automated assays (fourth-generation antigen test) for SARS-CoV-2 detection are promising because of their analytical productivity, but have lower sensitivity and specificity than rt-PCR assays. The authors...
7.
Giavarina D, Carta M
Diagnosis (Berl)
. 2021 Dec;
9(2):274-279.
PMID: 34851563
Objectives: A few CLIA automated immunoassays for the recognition of anti S1-RBD SARS-CoV-2 antibodies have recently been placed on the market. Preliminary data demonstrate a high correlation between methods but...
8.
Mahmud N, Maffei M, Mogni M, Forni G, Pinto V, Barberio G, et al.
Genes (Basel)
. 2021 Nov;
12(11).
PMID: 34828427
Background: Hemoglobin A (Hb A) (αβ) in the normal adult subject constitutes 96-98% of hemoglobin, and Hb F is normally less than 1%, while for hemoglobin A (Hb A) (αδ),...
9.
Carta M, Marinello I, Cappelletti A, Rodolfi A, Cerrito E, Bernasconi C, et al.
Am J Clin Pathol
. 2021 Aug;
157(2):212-218.
PMID: 34463321
Objectives: The Pfizer-BioNTech BNT162b2 vaccine against SARS-CoV-2 infection is now available. This vaccine induces antibody production against the receptor-binding domain (RBD) of the spike glycoprotein S1 (S1-RBD). This study evaluated...
10.
Carta M, Bragagnolo L, Tramarin A, Cappelletti A, Barzon E, Forner L, et al.
Clin Chem Lab Med
. 2021 Feb;
59(8):e322-e325.
PMID: 33641271
No abstract available.